Dementia: A Global Challenge Lecture Series

Dr. Eric M. Reiman

Eric M. Reiman, MD, UA professor of psychiatry; executive director, Banner Alzheimer’s Institute; CEO, Banner Research; clinical director of the Neurogenomics Division at the Translational Genomics Research Institute (TGen); and director of the Arizona Alzheimer’s Consortium
Date: Friday, June 3, 2016
Topic: “Accelerating the Evaluation of Alzheimer's Prevention Therapies

 

Arizona Health Science Center, Room 5403
8:00 - 9:00 AM

 

The “Dementia: A Global Challenge” lectures are a cooperative series sponsored by the UA Center on Aging, Arizona Geriatric Education Center, Healthy Brain Research Network (an initiative of the U.S. Centers for Disease Control and Prevention), UA Department of Neurology and Southern Arizona VA Health Care System. Funding was provided by the UA Center on Aging and Arizona Geriatrics Education Center. Both centers are affiliated with the UA Division of Geriatrics, General Internal Medicine and Palliative Medicine, which is part of the UA Department of Medicine.

As this lecture series coincides with UA Neurosciences Grand Rounds, they will be available for viewing livestreamed or archived afterward at this link. Each lecture will occur in Room 5403 of the UA College of Medicine – Tucson from 8 to 9 a.m. They are open to the public.

The series is facilitated by Steven Z. Rapcsak, MD, a UA professor of neurology, psychology, and speech, language and hearing sciences. Dr. Rapcsak has specialty training in behavioral neurology and cognitive neuroscience. His research interests include Alzheimer’s disease and related dementias, disorders of spoken and written language, memory and executive function.

Alzheimer’s disease and related dementias are among the biggest global public-health challenges. More than 45 million people live with dementia worldwide, according to Alzheimer’s Disease International. This number will double by 2030 and triple by 2050, to more than 130 million people. Worldwide costs to care for dementia are estimated at about $818 billion in 2015, nearly 1.09 percent of the world’s gross domestic product.

“The consequences of cognitive impairment, the toll on families and caregivers, and the decrements in quality of life of those directly and indirectly affected is enormous,” Dr. Rapcsak said. “This series will help us better understand and address these burdens.”

 

Past speakers in this lecture series included:

Duk L. Na, MD
Date: Friday, Nov. 20, 2015
Topic:  “Subcortical Vascular Cognitive Impairment.”

 

 

Dr. Irena Rektorová

Irena Rektorová, MD, PhD, associate professor of neurology at Masaryk University and head of the Centre for Cognitive Impairment and Dementia at St. Anne’s Teaching Hospital, and the Applied Neuroscience Research Group, Central European Institute of Technology, in Brno, Czech Republic.
Date: Friday, Jan. 22, 2016
Topic: “Parkinson’s Disease and Lewy Body Dementia”

 

 

 

Dr. Richard J. Casselli

Richard J. Caselli, MD, professor of neurology at Mayo Clinic in Scottsdale and director of the Clinical Core of the Arizona Alzheimer's Disease Core Center research project, funded by NIH.
Date: Friday, March 18, 2016
Topic: “Preclinical Alzheimer’s Disease”

 

Publish Date: 
Wednesday, May 11, 2016 - 13:15